Alyeska Investment Group, L.P.

Position in BIOA — BioAge Labs, Inc.

CIK 1453072 CHICAGO, IL

Back to BIOA Full portfolio

Position in BIOA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,311,750

-$1,808,250 QoQ

Shares Held

75,000

-50.0% QoQ

Ownership

0.169%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $190,720,824 across 3 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	5,519,030	$166,233,183
2	LNTH	Lantheus Holdings, Inc.	305,549	$23,175,891
3	BIOA	BioAge Labs, Inc. This page	75,000	$1,311,750

All Filings in BIOA

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,311,750	75,000	-50.0%	Shares	Sole	2026-05-15
2024-09-30	$3,120,000	150,000	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.